Sinotherapeutics Inc.

¥7.98As of Sun 8 Nov 2026, 12:00 UTC
SSE:688247Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (8.94%)
Div yield 0.44%
ROE 1.38%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM 181.3
TSR TTM (27.10%)
Mkt cap ¥3.583B
ROIC (0.52%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥8.05
0.84%
(86.33%)
Hold 9|2|9|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.08
0.09
13.97%
9.36%
(2.84%)
5.63%
Revenue¥M
302.1
295.6
292.5
298.3
(0.68%)
(2.38%)
(2.17%)
0.07%
Peers (US$537.1M)
Cap (US$)
PE
537.6M
166.6x
534.0M
18.71x
Capital
TTM
5Y
10Y
Leveragex
0.898
(0.045)
(0.037)
EBIT/Intx
1.019
0.439
0.405
Own earn%
21.13
(239.34)
(179.15)
Sh yield%
45.57
32.84
32.58
Owners
Insiders/Inst%
5.15
51.05
Short interest%
1.73
SBC / revenue%
5.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
1–12
$1 testx
0.8
Incr. ROIC%
10